Trevie Research is an oncology-focused clinical development and trial management advisory firm. With significant experience in biopharma drug development, commercialization initiatives, trial operations & analysis, as well as strong relationships with leading oncology KOLs and academia, Trevie partners with biotech, pharmaceutical, and non-profit organizations focused on Phase I/II drug development programs.
Looking for a particular Trevie Research employee's phone or email?
The Trevie Research annual revenue was $5 million in 2026.
Robert Wittig is the President and CEO of Trevie Research.
2 people are employed at Trevie Research.
Trevie Research is based in Cambridge, Massachusetts.
The NAICS codes for Trevie Research are [5417, 54, 541].
The SIC codes for Trevie Research are [87, 873].